Global Immunoassays Market 2023-2029

February 2023 | 81 pages | ID: GDA76E2D9CD9EN
Gen Consulting Company

Abstracts

An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. According to the latest data, the market size of the global immunoassays sector is expected to rise by USD 11.6 billion with a CAGR of 5.7% by the end of 2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global immunoassays market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for immunoassays can be segmented by product: analyzers, reagents & kits, software & services. Among these, the reagents & kits segment was accounted for the highest revenue generator in 2022. Immunoassays market is further segmented by technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA). The LFIA/MIA segment is estimated to account for the largest share of the global immunoassays market. Based on application, the immunoassays market is segmented into: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others. The infectious diseases segment held the largest share of the global immunoassays market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the immunoassays market also can be divided into: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others. In 2022, the hospitals and clinincs segment made up the largest share of revenue generated by the immunoassays market. Immunoassays market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

Market Segmentation

By product: analyzers, reagents & kits, software & services

By technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)

By application: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others

By end user: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others

By region: Asia Pacific, Europe, North America, Rest of the World (RoW)

The report has also analysed the competitive landscape of the global immunoassays market with some of the key players being Abbott Laboratories, Abcam plc, Becton, Dickinson and Company, bioMerieux, S.A., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, OraSure Technologies, Inc., Ortho Clinical Diagnostics Holdings plc, PerkinElmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global immunoassays market.
• To classify and forecast the global immunoassays market based on product, technology, application, end user, region.
• To identify drivers and challenges for the global immunoassays market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoassays market.
• To identify and analyze the profile of leading players operating in the global immunoassays market.

Why Choose This Report

• Gain a reliable outlook of the global immunoassays market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Analyzers
Reagents & kits
Software & services

PART 6. MARKET BREAKDOWN BY TECHNOLOGY

Enzyme immunoassay (ELISA)
Chemiluminescent immunoassay (CLIA)
Fluorescent immunoassay (FIA)
Radioimmunoassay (RIA)
Lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)

PART 7. MARKET BREAKDOWN BY APPLICATION

Cardiology
Diabetes
Drug screening
Infectious diseases
Oncology
Reproductive
Others

PART 8. MARKET BREAKDOWN BY END USER

Academia
Blood banks
Hospitals and clinincs
Pharmaceutical & biotech companies
Others

PART 9. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 10. KEY COMPANIES

Abbott Laboratories
Abcam plc
Becton, Dickinson and Company
bioMerieux, S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter Inc.)
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Merck & Co., Inc.
Meril Life Sciences Pvt. Ltd.
Mindray Medical International Limited
OraSure Technologies, Inc.
Ortho Clinical Diagnostics Holdings plc
PerkinElmer, Inc.
Quidel Corporation
Randox Laboratories Ltd.
SD Biosensor, Inc.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER